Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 4/20 | 0.53 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.50 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.50 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.47 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | PGR | P06401 | 2/20 | 0.43 |
| ▸ | GRM5 | P41594 | 1/20 | 0.43 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.42 |
| ▸ | ERN1 | O75460 | 1/20 | 0.42 |
| ▸ | DRD2 | P14416 | 2/20 | 0.41 |
| ▸ | DRD4 | P21917 | 2/20 | 0.41 |
| ▸ | DRD3 | P35462 | 2/20 | 0.41 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.40 |
| ▸ | PRF1 | P14222 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7505848 | 0.91 | HSD17B1 (0.55) | HSD17B1SRD5A1CYP1A2CYP11B1CYP11B2 | |
| SCHEMBL31358816 | 0.79 | ADORA1 (0.55) | SRD5A1CYP11B1CYP11B2SLC6A11KCNH2 | |
| SCHEMBL2238249 | 0.79 | ADORA1 (0.55) | SRD5A1CYP11B1CYP11B2SLC6A11KCNH2 | |
| SCHEMBL15570510 | 0.79 | PARP11 (0.62) | SLC6A11GRM5PRF1 | |
| SCHEMBL28655414 | 0.78 | HSD17B1 (0.78) | HSD17B1CYP1A2CYP11B1CYP11B2CASP1 | |
| SCHEMBL4243227 | 0.78 | SLC6A11 (0.48) | HSD17B1SRD5A1SLC6A11KCNH2PGR | |
| SCHEMBL15570926 | 0.77 | DRD2 (0.52) | SRD5A1SLC6A11GRM5DRD2DRD4 | |
| SCHEMBL27690419 | 0.76 | MAOB (0.51) | SLC6A11KCNH2PGRGRM5 | |
| SCHEMBL15570741 | 0.75 | CLK4 (0.54) | SLC6A11KCNH2PGRGRM5PRF1 | |
| SCHEMBL1745161 | 0.74 | HSD17B1 (0.71) | HSD17B1SRD5A1CYP1A2CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104910053-B | Asymmetric two oxime ester compound and its manufacture method and application | 北京英力科技发展有限公司 | 2017-09-12 | — | — | CN | disclosed |
| CN-103998422-B | Cyclopentanedione oxime ester and application thereof | 北京英力科技发展有限公司 | 2016-11-30 | — | — | CN | disclosed |
| CN-104910053-A | Asymmetric dioxime ester compound, making method and application thereof | INSIGHT HIGH TECHNOLOGY BEIJING CO LTD | 2015-09-16 | — | — | CN | disclosed |
| CN-103998422-A | Cyclopentadiketoxime ester and applications thereof | BEIJING INSIGHT HIGH TECHNOLOGY CO LTD | 2014-08-20 | — | — | CN | disclosed |
| EP-1501514-B1 | PROTEIN KINASE MODULATORS AND METHODS OF USE | EXELIXIS INC (US) | 2012-12-19 | — | — | EP | disclosed |
| CN-101119965-B | Tetralin and indane derivatives and uses thereof | HOFFMANN LA ROCHE | 2012-09-26 | — | — | CN | disclosed |
| US-7704995-B2 | Protein kinase modulators and methods of use | EXELIXIS, INC. (US) | 2010-04-27 | — | — | US | disclosed |
| EP-1501514-A4 | PROTEIN KINASE MODULATORS AND METHODS OF USE | EXELIXIS INC (US) | 2009-08-26 | — | — | EP | disclosed |
| CN-101124210-A | Tetrahydronaphthalene and indane derivatives and their use | ROCHE PALO ALTO LLC (CH) | 2008-02-13 | — | — | CN | disclosed |
| CN-101119965-A | Tetralin and indane derivatives and uses thereof | ROCHE PALO ALTO LLC (CH) | 2008-02-06 | — | — | CN | disclosed |
| CN-101111472-A | 1,2,3, 4-tetrahydronaphthalene and indane derivatives and their use as 5-HT antagonists | HOFFMANN LA ROCHE (CH) | 2008-01-23 | — | — | CN | disclosed |
| US-20060211709-A1 | Protein kinase modulators and methods of use | EXELIXIS, INC. | 2006-09-21 | — | — | US | disclosed |
| EP-1501514-A2 | PROTEIN KINASE MODULATORS AND METHODS OF USE | Exelixis, Inc. (US) | 2005-02-02 | — | — | EP | disclosed |
| EP-1119557-B1 | INDENO-, NAPHTO- AND BENZOCYCLOHEPTA DIHYDROTHIAZOLE DERIVATIVES, THE PRODUCTION THEREOF AND THEIR USE AS ANORECTIC MEDICAMENTS | AVENTIS PHARMA GMBH (DE) | 2003-12-03 | — | — | EP | disclosed |
| WO-2003093297-A2 | PROTEIN KINASE MODULATORS AND METHODS OF USE | EXELIXIS, INC. (US) | 2003-11-13 | — | — | WO | disclosed |
| EP-1119557-A1 | INDENO-, NAPHTO- AND BENZOCYCLOHEPTA DIHYDROTHIAZOLE DERIVATIVES, THE PRODUCTION THEREOF AND THEIR USE AS ANORECTIC MEDICAMENTS | Aventis Pharma Deutschland GmbH (DE) | 2001-08-01 | — | — | EP | disclosed |
| US-6090833-A | EATING DISORDERS; ANTIDIABETIC AGENT | AVENTIS PHARMA DEUTSCHAND GMBH (DE) | 2000-07-18 | — | — | US | disclosed |
| WO-2000018749-A1 | INDENO-, NAPHTO- AND BENZOCYCLOHEPTA DIHYDROTHIAZOLE DERIVATIVES, THE PRODUCTION THEREOF AND THEIR USE AS ANORECTIC MEDICAMENTS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-04-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060211709-A1 | Protein kinase modulators and methods of use | GRK2, MAP4K2, MAPKAPK2 | HSD17B1 2835/4885SRD5A1 3529/4885CYP1A2 3108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.